These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12349894)

  • 21. Multimodal prophylaxis in patients with a history of venous thromboembolism undergoing primary elective hip arthroplasty.
    Gonzalez Della Valle A; Shanaghan KA; Nguyen J; Liu J; Memtsoudis S; Sharrock NE; Salvati EA
    Bone Joint J; 2020 Jul; 102-B(7_Supple_B):71-77. PubMed ID: 32600195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deep vein thrombosis prophylaxis: better living through chemistry--in the affirmative.
    Kwong LM
    J Arthroplasty; 2005 Jun; 20(4 Suppl 2):12-4. PubMed ID: 15991121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extended-duration low-molecular-weight heparin prophylaxis following total joint arthroplasty.
    Whang PG; Lieberman JR
    Am J Orthop (Belle Mead NJ); 2002 Sep; 31(9 Suppl):31-6. PubMed ID: 12349893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of a nomogram and physician-adjusted dosage of warfarin for prophylaxis against deep-vein thrombosis after arthroplasty.
    Anderson DR; Wilson SJ; Blundell J; Petrie D; Leighton R; Stanish W; Alexander D; Robinson KS; Burton E; Gross M
    J Bone Joint Surg Am; 2002 Nov; 84(11):1992-7. PubMed ID: 12429760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety of perioperative subcutaneous heparin for prophylaxis of venous thromboembolism in patients undergoing craniotomy.
    Macdonald RL; Amidei C; Lin G; Munshi I; Baron J; Weir BK; Brown F; Erickson RK; Hekmatpanah J
    Neurosurgery; 1999 Aug; 45(2):245-51; discussion 251-2. PubMed ID: 10449068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prophylaxis for Venous Thromboembolic Events in Elective Total Hip and Total Knee Arthroplasty.
    Karasavvidis T; Bouris V; Xiang W; Tzavellas G; Charisis N; Palaiodimos L; Kigka V; Bourantas CV; Gkiatas I
    Curr Pharm Des; 2022; 28(10):771-777. PubMed ID: 35440299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials.
    Eikelboom JW; Quinlan DJ; Douketis JD
    Lancet; 2001 Jul; 358(9275):9-15. PubMed ID: 11454370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of venous thromboembolic disease after total hip and knee arthroplasty.
    Lieberman JR; Hsu WK
    J Bone Joint Surg Am; 2005 Sep; 87(9):2097-112. PubMed ID: 16140827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Venous thromboembolic disease after total hip and knee arthroplasty: current perspectives in a regulated environment.
    Pellegrini VD; Sharrock NE; Paiement GD; Morris R; Warwick DJ
    Instr Course Lect; 2008; 57():637-61. PubMed ID: 18399613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The John Charnley Award: prevention of readmission for venous thromboembolic disease after total hip arthroplasty.
    Pellegrini VD; Donaldson CT; Farber DC; Lehman EB; Evarts CM
    Clin Orthop Relat Res; 2005 Dec; 441():56-62. PubMed ID: 16330984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of preoperative donation of autologous blood on deep-vein thrombosis after total hip arthroplasty.
    Bae H; Westrich GH; Sculco TP; Salvati EA; Reich LM
    J Bone Joint Surg Br; 2001 Jul; 83(5):676-9. PubMed ID: 11476304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical experience with ximelagatran in orthopaedic surgery.
    Eriksson B
    Drugs; 2004; 64 Suppl 1():27-35. PubMed ID: 15586625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Venous thromboembolic prophylaxis after elective total hip arthroplasty.
    Conduah A; Lieberman JR
    Clin Orthop Relat Res; 2005 Dec; 441():274-84. PubMed ID: 16331015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rationale for thromboprophylaxis in lower joint arthroplasty.
    Colwell CW
    Am J Orthop (Belle Mead NJ); 2007 Sep; 36(9 Suppl):11-3. PubMed ID: 17948162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Duration of venous thromboembolism prophylaxis after surgery.
    Kearon C
    Chest; 2003 Dec; 124(6 Suppl):386S-392S. PubMed ID: 14668422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Standards and perspectives for thromboembolism prophylaxis].
    Rader CP
    Orthopade; 2007 Jun; 36(6):560, 562-6. PubMed ID: 17546440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for clinically relevant pulmonary embolism and deep venous thrombosis in patients undergoing primary hip or knee arthroplasty.
    Mantilla CB; Horlocker TT; Schroeder DR; Berry DJ; Brown DL
    Anesthesiology; 2003 Sep; 99(3):552-60; discussion 5A. PubMed ID: 12960538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Temporal trends in prevention of venous thromboembolism following primary total hip or knee arthroplasty 1996-2001: findings from the Hip and Knee Registry.
    Anderson FA; Hirsh J; White K; Fitzgerald RH;
    Chest; 2003 Dec; 124(6 Suppl):349S-356S. PubMed ID: 14668417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypotensive epidural anesthesia for total hip arthroplasty: a review.
    Sharrock NE; Salvati EA
    Acta Orthop Scand; 1996 Feb; 67(1):91-107. PubMed ID: 8615115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aspirin for elective hip and knee arthroplasty: a multimodal thromboprophylaxis protocol.
    Vulcano E; Gesell M; Esposito A; Ma Y; Memtsoudis SG; Gonzalez Della Valle A
    Int Orthop; 2012 Oct; 36(10):1995-2002. PubMed ID: 22684546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.